Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Catheter Cardiovasc Interv. 2012 Aug 1;80(2):E9-14. doi: 10.1002/ccd.23196. Epub 2011 Dec 8.
This study examined outcomes of patients with sudden cardiac death attributable to primary ventricular tachycardia (VT) or ventricular fibrillation (VF) that underwent cardiac catheterization with or without percutaneous coronary intervention (PCI).
The decision to perform cardiac catheterization and PCI in resuscitated patients with sudden cardiac death remains controversial. Prior data suggest a potential benefit from percutaneous revascularization.
All patients with an in-hospital pulseless VT or VF cardiac arrest from August 2002 to February 2008 who underwent cardiac catheterization were included. Retrospective chart review was performed to obtain clinical, neurologic, and angiographic data. Primary endpoints were all-cause mortality and neurologic outcome.
Two thousand and thirty-four patients had in-hospital cardiac arrest, of these 116 had pulseless VT or VF and were resuscitated and 93 (80%) underwent coronary angiography. The median time to follow-up was 1.3 years (IQR: 0.5-2.9 years). Obstructive coronary artery disease (CAD) was observed in 74 (79%) individuals, of whom 37 underwent PCI. Thirty-five patients with obstructive CAD (47%) died compared to 41% with nonobstructive CAD. In unadjusted and multivariable adjusted analysis PCI was not associated with lower mortality (adjusted hazard ratio: 1.54, 95% CI, 0.79-3.02, P = 0.20). No significant differences were noted in neurologic status at discharge (P = 0.49).
In this study, an aggressive revascularization strategy with PCI did not confer a survival advantage nor was it associated with improved neurologic outcomes. There was no suggestion of harm with PCI and further studies are necessary to identify potential subgroups that may benefit from revascularization.
本研究旨在探讨原发性室性心动过速(VT)或心室颤动(VF)导致心搏骤停患者接受心脏导管检查联合或不联合经皮冠状动脉介入治疗(PCI)的结局。
对心搏骤停复苏患者行心脏导管检查和 PCI 的决策仍存在争议。先前的数据表明经皮血运重建可能有益。
纳入 2002 年 8 月至 2008 年 2 月期间因院内无脉性 VT 或 VF 心脏骤停而行心脏导管检查的所有患者。回顾性病历审查以获取临床、神经和血管造影数据。主要终点为全因死亡率和神经结局。
2034 例患者发生院内心脏骤停,其中 116 例为无脉性 VT 或 VF 并复苏,93 例(80%)接受了冠状动脉造影。中位随访时间为 1.3 年(IQR:0.5-2.9 年)。74 例(79%)患者存在阻塞性冠状动脉疾病(CAD),其中 37 例行 PCI。35 例阻塞性 CAD 患者(47%)死亡,而非阻塞性 CAD 患者为 41%。未校正和多变量校正分析均显示 PCI 与死亡率降低无关(校正后的危险比:1.54,95%CI:0.79-3.02,P=0.20)。出院时神经状态无显著差异(P=0.49)。
在这项研究中,积极的血运重建策略(PCI)并未带来生存优势,也与改善的神经结局无关。PCI 并未增加危害,进一步的研究需要确定可能从血运重建中获益的潜在亚组。